top of page
Abstract Curves


Meet the Founder


CEO & Founder of Enigma Therapeutics

  • LinkedIn

Jonathan Ahmet, our CEO, is the Founder of Enigma Therapeutics LLC in the US and concurrently serves as the Director of its complimentary subsidiary Enigma Therapeutics India Private Limited.

Graduating in 2013 with a Masters in Chemistry from the University of Sussex in Brighton, UK, he specialized in organic chemistry. His focus on molecules targeting neglected diseases and the central nervous system during summer placements and a master's project demonstrated his dedication to impactful research. He also spent his third year on a study abroad exchange at Waterloo University in Ontario, Canada, where he developed a keen interest for natural products when enrolled in an international student lab programme that focused on the synthesis of the kinamycin antibiotics and its analogues.

Opting for industry experience over a Ph.D, his professional journey commenced at RedX Oncology in Liverpool, UK, where he held a pivotal role as a synthetic organic/medicinal chemist developing cancer drugs, followed by a similar position at Cancer Research UK Manchester Institute. He then ventured into contract work at Charnwood Molecular, a Contract Research Organization (CRO) in Nottingham, UK where he worked across many projects targeting a range of disease areas. He then obtained a position at GW Pharmaceuticals, where he contributed to the development of cannabinoid medicines. 

Throughout his career, Jonathan has undertaken several global freelance roles in scientific journal editing and chemistry consultation, the latter leading to the direction and management of custom synthesis projects with CROS in Bangladesh, China, and India. Leveraging this extensive experience, he founded Enigma Therapeutics LLC in the US and is currently establishing a complementary Indian subsidiary.


Would you like to become a part of our team?

We currently don't have any open positions available, but we warmly welcome initiative applications. 


Enigma Therapeutics has been in development for two years, meticulously navigating the global chemical landscape across Europe, the US, and Asia. Recognizing the continued significance of the West in Drug Discovery, our headquarters resides in the US, while we strategically chose India for our subsidiary, considering its pivotal role in the ongoing industrial revolution and emerging prominence in chemical manufacturing. Harnessing the skilled workforce and leveraging cost-effective personal and facilities, we aim to optimize our operations for unparalleled success.


While we are establishing our branch in India with a laboratory offering a curated selection of services, we are currently working on partnerships with various Indian companies e.g., CROs and analytical service providers.

If you are part of or know an organization that would fit our business vision, please reach out to us. We are always excited to meet other innovators in the pharmaceutical sector. 

bottom of page